Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Net service ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.

Amedisys is being acquired by UnitedHealth for $3.3B, pending DOJ approval. Learn why UNH and AMED stock are impacted by ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers in a last-ditch effort to persuade the agency not to challenge their ...

BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...